Listly by The Prostate Seed Institute
One of the more common ways doctors determine the aggressiveness of prostate cancer is assigning it to a Prostate Cancer Risk Group.
The PSA test is designed to gauge the level of prostate-specific antigen proteins in a man’s blood. This protein is produced naturally in the prostate gland.
The prostate is a combination of glands, ducts, and muscle tissue. It is part of the male reproductive system.
Prostate Seed Institute’s founder is Dr. Gregory Echt, a leading radiation oncologist has professionally committed his life to providing cancer patients with the most effective treatments available.
Selecting a prostate cancer treatment can be a difficult process for men and their doctors. While this form of cancer is often highly treatable, each intervention comes with its own potential side effects.
Screenings are a normal part of routine healthcare and are begun at certain ages to establish a baseline so that if cancer does develop, changes will be identified easier during screenings.
Prostate cancer is typically a slow-growing disease and, therefore, does not result in the development of any symptoms, especially in the early stages.
When told that you have prostate cancer, understandably your first reaction is shock, and maybe disbelief. After all, it is a disease that doesn’t show many symptoms, and occurs in only one out of seven men in the US.
Even though treatment for prostate cancer is available in many forms such as chemotherapy, or hormonal therapy, in many men, the disease will grow further and progress in spite of treatment.
Recent studies have surfaced that complete Mediterranean dietary patterns could decrease the possibility of a person with being afflicted with prostate cancer in comparison to a person who consumes discrete foods.
Polygenetic hazardous scores can be used for the personalizing of genetic risk, and thus, prostate cancer can be predicted, though more research into this is needed.
Early screening is recommendable to reduce the cost of treatment and to catch prostate cancer at its earlier stages to help eradicate this disease. Effective cancer screenings can help to lower the number of deaths relating to prostate cancer.
PSA screening test results are certainly not accurate and perfect. The test may show abnormal signs when in fact, the patient is fine.
The U.S. government advisory panel has left the for men to decide on their own. They can have a consultation with their doctor and then decide for themselves if they should opt for a PSA screening test.